JAMA: Half of U.S. population either pre-diabetic or diabetic FDA approves updated labeling for Simponi Aria Study: PrEP demonstrates effectiveness, but alongside growing STI rate FDA approves Brilinta 60 mg tablets Sandoz introduces rivastigmine patch Kaleo launches campaign on safe opioid use Novartis, Amgen team on migraine, Alzheimer’s drug development Teva launches Zecuity migraine patch PrescribeWellness intros PrescribeMedicare FDA unveils draft guidance for naming biosimilars First Previous 121 122 123 124 125 Next Last
